1. Home
  2. LASE vs INO Comparison

LASE vs INO Comparison

Compare LASE & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laser Photonics Corporation

LASE

Laser Photonics Corporation

HOLD

Current Price

$2.74

Market Cap

92.7M

Sector

Industrials

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.12

Market Cap

90.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASE
INO
Founded
2019
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
90.5M
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
LASE
INO
Price
$2.74
$1.12
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
30.9M
1.8M
Earning Date
04-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
$721,185.00
$42,220,086.00
Revenue This Year
N/A
$20,156.19
Revenue Next Year
N/A
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.37
52 Week Low
$0.38
$1.03
52 Week High
$6.77
$2.86

Technical Indicators

Market Signals
Indicator
LASE
INO
Relative Strength Index (RSI) 61.42 41.69
Support Level $1.90 $1.03
Resistance Level $3.06 $1.23
Average True Range (ATR) 0.70 0.06
MACD -0.01 -0.01
Stochastic Oscillator 50.02 18.33

Price Performance

Historical Comparison
LASE
INO

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasive blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, machine manufacturing, nuclear maintenance and decommissioning, and surface coating. Geographically, the company generates almost all of its revenue from the domestic market.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: